Regeneron Pharmaceuticals REGN
NASDAQ REGN
$897.19 -5.71 (-0.63%)
As of: Nov 6, 2026 · 10:06 AM EST

Regeneron Pharmaceuticals (REGN) Other Non Operating Income (2013 - 2026)

Updated

Regeneron Pharmaceuticals' Other Non Operating Income was $246.5 million in Q3 2026, down 67.4% from $755.8 million a year earlier but up 0.5% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Other Non Operating Income (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Other Non Operating Income was $869 million through Sep 30, 2026, down 42.0% year-over-year; for FY2025, it was $1.7 billion, up 100.9% from FY2024.

  • Other Non Operating Income has now increased for three consecutive years, with a five-year compound annual growth rate of 42.3% (FY2020 to FY2025).
  • In earlier years, Other Non Operating Income was $844.4 million in FY2024 (+275.0%), $225.2 million in FY2023 (+25.6%), $179.3 million in FY2022 (-58.9%) and $436.3 million in FY2021 (+50.1%).
  • Quarterly Other Non Operating Income has moved between -$183.8 million (Q1 2022) and $755.8 million (Q3 2025) over five years.
  • Compared with a year earlier, Other Non Operating Income has declined for three straight quarters, with an average decline of 8.3% over the last five quarters.
  • The best year-over-year quarter for Other Non Operating Income over five years was Q2 2024 (growth of 572.1%); the worst was Q3 2023 (a decline of 94.2%).
  • Per Business Quant data, REGN's Other Non Operating Income in the three quarters before Q3 2026 was $245.3 million (Q2 2026), $201.2 million (Q1 2026) and $176 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.28 Bn 1,194.89 Bn 20.46 Bn
2 Johnson & Johnson 653.62 Bn 573.48 Bn 17.30 Bn
3 AbbVie 509.01 Bn 477.02 Bn 13.12 Bn
4 Merck 362.31 Bn 325.26 Bn 13.19 Bn
5 Novartis Ag 312.49 Bn 285.73 Bn -
6 Astrazeneca 285.84 Bn 259.73 Bn 13.26 Bn
7 Amgen 248.19 Bn 199.85 Bn 7.58 Bn
8 Gilead Sciences 208.17 Bn 183.27 Bn 6.73 Bn
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn
10 Regeneron Pharmaceuticals 91.66 Bn 57.01 Bn 4.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 246.50 Mn
Jun 30, 2026 245.30 Mn
Mar 31, 2026 201.20 Mn
Dec 31, 2025 176.00 Mn
Sep 30, 2025 755.80 Mn
Jun 30, 2025 442.80 Mn
Mar 31, 2025 322.00 Mn
Dec 31, 2024 -21.60 Mn
Sep 30, 2024 327.30 Mn
Jun 30, 2024 573.30 Mn
Mar 31, 2024 -34.60 Mn
Dec 31, 2023 193.00 Mn
Sep 30, 2023 17.60 Mn
Jun 30, 2023 85.30 Mn
Mar 31, 2023 -70.70 Mn
Dec 31, 2022 195.30 Mn
Sep 30, 2022 301.40 Mn
Jun 30, 2022 -133.60 Mn
Mar 31, 2022 -183.80 Mn
Dec 31, 2021 -122.20 Mn
API Access

Regeneron Pharmaceuticals Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=REGN&period=max&api_key=YOUR_API_KEY